Head-to-head · WeighScore
Eve vs Unique Physique
The verdict
Eve takes it — 66/100 to 61.4/100.
Eve grades higher on WeighScore, our editorial score across cost value, dose & formulation, clinical oversight, labs & monitoring, fulfillment and contract terms. Eve is a women's-health-focused GLP-1 telehealth platform — distinctive positioning in a largely gender-neutral market — offering both compounded semaglutide and tirzepatide (including an oral sublingual…
We may earn a commission if you start care through some of these links, at no extra cost to you. It never moves the WeighScore, which is the weighted average of the six factors shown for every provider, and what we write about a provider is the same either way. See our disclosure.
Factor by factor
The same six graded dimensions, side by side. See the methodology.
The numbers
| Metric | Eve | Unique Physique |
|---|---|---|
| WeighScore | 66/100 | 61.4/100 |
| Grade | C | C |
| Scorecard rank | #210 | #296 |
| Semaglutide | $195/mo (compounded) | Not disclosed |
| Tirzepatide | $195/mo (compounded) | Not disclosed |
| Coverage | Coverage not published | Coverage not published |
| Brand-name access | Yes | Yes |
| Oral / sublingual | Yes | Injection only |
Graded #210 · C
Strengths
- Genuinely women's-health-focused — fills a real gap among gender-neutral GLP-1 competitors
- Both compounded and brand-name FDA-approved options (Wegovy/Ozempic/Mounjaro) on one platform — rare
- LegitScript Certified with a verifiable ID
- Publishes the FDA compounded-medication disclaimer
- Oral sublingual semaglutide offered alongside injectable
Where it loses points
- Full states-served list not disclosed publicly
- 503A pharmacy partner not named, and 503A vs 503B status not specified
- Named medical director / clinical leadership not disclosed
- Corporate legal entity not disclosed
- Governing law / arbitration venue not stated
Graded #296 · C
Strengths
- Legal entity disclosed (Unique Physique, LLC) with Louisiana governing law — better than opaque DTC competitors
- Named medical director (Reena John, DO) — uncommon at this price tier
- Brick-and-mortar clinic in Baton Rouge, LA offers an in-person option vs ship-only competitors
- Transparent two-tier flat pricing ($195/mo and $325/mo) — no dose-escalation surprises
- Brand-name routing option ($25/mo) sends an Rx to your own pharmacy for Wegovy/Zepbound/Ozempic/Mounjaro
Where it loses points
- GLP-1 drug molecules aren't named on the pricing or service pages — you can't confirm what the $195/mo and $325/mo plans contain without calling
- Pharmacy partner not named — can't verify licensure or 503A vs 503B status
- No FDA compounded-medication disclaimer on any audited page
- States served not listed — only "licensed clinicians in the patient's state"
- Non-refundable per the Terms; medication not picked up within 60 days is discarded with no refund
Also worth a look
Neither is our top-graded pick — CoreAge Rx leads the scorecard
Across all 499 providers, CoreAge Rx grades highest at 91.8/100 (A−). Top of the scorecard: flat transparent pricing, both molecules, nationwide — no teaser-rate games.
Pricing/verification reflect each provider's public disclosures at last grading; the WeighScore is our editorial judgment per the methodology. Prices change — confirm on each provider's site. Not medical advice; see our disclosure.